Nephrogen

Nephrogen is a preclinical biotech company developing curative genomic medicines for serious diseases. Our initial focus is on kidney and pancreatic diseases, which affect 1 in 5 Americans but are notoriously difficult to treat with genomic medicine because of delivery challenges.